Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability

Pharmaceutical Development and Technology

Volumn 19, Issue 8, 2014, Pages 976-986

  Wegiel, Lindsay A ^a   Zhao, Yuhong ^b,c   Mauer, Lisa J ^b   Edgar, Kevin J ^d   Taylor, Lynne S ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c NORTHEAST FORESTRY UNIVERSITY   (China)

^d VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Amorphous; Curcumin; FTIR; Hydrogen bonding; Physical stability; Polymers; Solid dispersion

Indexed keywords

BUTYRIC ACID DERIVATIVE; CARBOXYMETHYL CELLULOSE ACETATE BUTYRATE; CURCUMIN; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE ACETATE SUCCINATE; POVIDONE; UNCLASSIFIED DRUG;

AMORPHOUS SOLID DISPERSION; ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STABILITY; EVAPORATION; GLASS TRANSITION TEMPERATURE; HYDROGEN BOND; INFRARED SPECTROSCOPY; MISCIBILITY; MOLECULAR INTERACTION; PHARMACOLOGICAL PROCEDURES; PRIORITY JOURNAL; STORAGE; TAUTOMER; ULTRAVIOLET SPECTROSCOPY; ULTRAVIOLET VISIBLE SPECTROSCOPY;

ACRYLATES; ANTINEOPLASTIC AGENTS; CARBOXYMETHYLCELLULOSE SODIUM; CRYSTALLIZATION; CURCUMIN; DRUG STABILITY; EXCIPIENTS; HYDROGEN BONDING; METHYLCELLULOSE; POLYMERS; POVIDONE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84890415145     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2013.846374     Document Type: Article

References (48)

1. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 1976;25:1811-1812
2. Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase- 1 and protects endothelial cells against oxidative stress. Free Radical Biol Med 2000;28:1303-1312
3. Apisariyakul A, Vanittanakom N, Buddhasukh D. Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharmacol 1995;49:163-169
4. Sadzuka Y, Nagamine M, Toyooka T, et al. Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin. Int J Pharm 2012;432:42-49
5. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 2003; 23:363-398
6. Vlietinck AJ, De Bruyne T, Apers S, Pieters LA. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med 1998;64:97-109
7. Sergent T, Vanderstraeten J, Winand J, et al. Phenolic compounds and plant extracts as potential natural anti-obesity substances. Food Chem 2012;135:68-73
8. Miriyala S, Panchatcharam M, Rengarajulu P. Cardioprotective effects of curcumin. Adv Exp Med Biol 2007;595:359-377
9. Tonnesen HH, Masson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: Solubility, chemical and photochemical stability. Int J Pharm 2002;244:127-135
10. Wang Y-J, Pan M-H, Cheng A-L, et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997;15:1867-1876
11. Priyadarsini KI. Photophysics, photochemistry and photobiology of curcumin: Studies from organic solutions, bio-mimetics and living cells. J Photochem Photobiol C-Photochem Rev 2009;10:81-95
12. Anand P, Nair HB, Sung BK, et al. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 2010;79:330-338
13. Paradkar A, Ambike AA, Jadhav BK, Mahadik KR. Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int J Pharm 2004;271:281-286
14. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47-60
15. Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999;88:1058-1066
16. Rumondor ACF, Stanford LA, Taylor LS. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions. Pharm Res 2009;26: 2599-2606
17. Rumondor ACF, Marsac PJ, Stanford LA, Taylor LS. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Mol Pharmaceutics 2009;6:1492-1505
18. Van Eerdenbrugh B, Taylor LS. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation. Mol Pharm 2010;7:1328-1337
19. Van Eerdenbrugh B, Baird JA, Taylor LS. Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation - classification and comparison with crystallization tendency from undercooled melts. J Pharm Sci 2010;99:3826-3838
20. Kestur US, Taylor LS. Role of polymer chemistry in influencing crystal growth rates from amorphous felodipine. Cryst Eng Comm 2010;12:2390-2397
21. Kestur US, Van Eerdenbrugh B, Taylor LS. Influence of polymer chemistry on crystal growth inhibition of two chemically diverse organic molecules. Cryst Eng Comm 2011;13:6712-6718
22. Van Eerdenbrugh B, Taylor LS. An ab initio polymer selection methodology to prevent crystallization in amorphous solid dispersions by application of crystal engineering principles. Cryst Eng Comm 2011;13:6171-6178
23. Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage - impact of different polymers. J Pharm Sci 2013;102: 171-184
24. Jasim F, Ali F. A novel and rapid method for the spectrofluorometric determination of curcumin in curcumin spices and flavors. Microchem J 1992;46:209-214
25. Marsac PJ, Shamblin SL, Taylor LS. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm Res 2006;23:2417-2426
26. Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 1997;14:1691-1698
27. Parimita SP, Ramshankar YV, Suresh S, Row TNG. Redetermination of curcumin: (1E,4Z,6E)-5-hydroxy-1,7- bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6- Trien-3-one. Acta Crystallographica Section E-Structure Reports Online 2007;63: O860-O862
28. Sanphui P, Goud NR, Khandavilli UBR, et al. New polymorphs of curcumin. Chem Commun 2011;47:5013-5015
29. Gilli G, Bellucci F, Ferretti V, Bertolasi V. Evidence for resonanceassisted hydrogen-bonding from crystal-structure correlations on the enol form of the beta-diketone fragment. J Am Chem Soc 1989;111: 1023-1028
30. Benassi R, Ferrari E, Lazzari S, et al. Theoretical study on curcumin: A comparison of calculated spectroscopic properties with NMR, UV-vis and IR experimental data. J Mol Struct 2008;892: 168-176
31. Tang XC, Pikal MJ, Taylor LS. A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers. Pharm Res 2002;19: 477-483
32. Moustafine RI, Zaharov IM, Kemenova VA. Physicochemical characterization and drug release properties of Eudragit E PO/ Eudragit L 100-55 interpolyelectrolyte complexes. Eur J Pharm Biopharm 2006;63:26-36
33. Miyazaki T, Yoshioka S, Aso Y. Physical stability of amorphous acetanilide derivatives improved by polymer excipients. Chem Pharmaceut Bull 2006;54:1207-1210
34. Weuts I, Kempen D, Verreck G, et al. Salt formation in solid dispersions consisting of polyacrylic acid as a carrier and three basic model compounds resulting in very high glass transition temperatures and constant dissolution properties upon storage. Eur J Pharm Sci 2005;25:387-393
35. Yoo SU, Krill SL, Wang Z, Telang C. Miscibility/stability considerations in binary solid dispersion systems composed of functional excipients towards the design of multi-component amorphous systems. J Pharm Sci 2009;98:4711-4723
36. Kuswandi B, Jayus TS, Larasati A, et al. Real-Time monitoring of shrimp spoilage using on-package sticker sensor based on natural dye of curcumin. Food Anal Methods 2012;5:881-889
37. Etter MC. Encoding and decoding hydrogen-bond patterns of organic compounds. Acc Chem Res 1990;23:120-126
38. Etter MC. Hydrogen bonds as design elements in organic chemistry. J Phys Chem 1991;95:4601-4610
39. Menjoge AR, Kulkarni MG. Mechanistic investigations of phase behavior in Eudragit (R) blends. Int J Pharm 2007;343:106-121
40. Bernabe-Pineda M, Ramirez-Silva MT, Romero-Romo M, et al. Determination of acidity constants of curcumin in aqueous solution and apparent rate constant of its decomposition. Spectrochim Acta A Mol Biomol Spectrosc 2004;60:1091-1097
41. Guzman ML, Manzo RH, Olivera ME. Eudragit E100 as a drug carrier: The remarkable affinity of phosphate ester for dimethylamine. Mol Pharm 2012;9:2424-2433
42. Quinteros DA, Rigo VR, Kairuz AEJ, et al. Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs. Eur J Pharm Sci 2008;33:72-79
43. Van den Mooter G, Wuyts M, Blaton N, et al. Physical stabilization of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci 2001;12:261-269
44. Lu Q, Zografi G. Phase behavior of binary and ternary amorphous mixtures containing indomethacin, citric acid, and PVP. Pharm Res 1998;15:1202-1206
45. Tong P, Zografi G. Solid-state characteristics of amorphous sodium indomethacin relative to its free acid. Pharm Res 1999;16: 1186-1192
46. Tong P, Zografi G. A study of amorphous molecular dispersions of indomethacin and its sodium salt. J Pharm Sci 2001;90:1991-2004
47. Fox TG. Influence of diluent and of copolymer composition on the glass temperature of a polymer system. Bull Am Phys Soc 1956; 1:123
48. Shamblin SL, Taylor LS, Zografi G. Mixing behavior of colyophilized binary systems. J Pharm Sci 1998;87:694-701